Mucositis and salivary antioxidants in patients undergoing bone marrow transplantation (BMT)

• Published in: Medicina oral, patología oral y cirugía bucal Vol. 19; no. 5; pp. e444 - e450
• Main Authors: Bachmeier, Evelin, Mazzeo, Marcelo-Adrián, López, María-Marcela, Linares, Jorge-Alberto, Jarchum, Gustavo, Wietz, Fernando-Martín, Finkelberg, Ana-Beatriz
• Format: Journal Article
• Language: English
• Published: Spain Medicina Oral S.L 01-09-2014
• Subjects: Adult; Aged; Bone Marrow Transplantation; Dentistry; Female; Humans; Longitudinal Studies; Male; Middle Aged; Mucositis - metabolism; Postoperative Complications - metabolism; Saliva - chemistry; Superoxide Dismutase - analysis; Uric Acid - analysis
• ISSN: 1698-6946; 1698-4447; 1698-6946
• DOI: 10.4317/medoral.19062

High doses of chemotherapy generate DNA damage in patients undergoing bone marrow transplantation (BMT), due to the production of reactive oxygen species (ROS). In order to evaluate the local defensive effectiveness of the patient undergoing BMT, the concentrations of the antioxidants superoxide dismutase (SOD) and uric acid (UA) were measured in saliva.
Basal saliva samples were collected from 20 patients undergoing BMT at the Oncology Department, Sanatorio Allende (Córdoba), in the stages: initial, prior to conditioning therapy (I); middle: 7 to 10 days after BMT (M) and final stage, 30 days after discharge from isolation (F). SOD levels were determined using a RANDOX kit (RANSOD superoxide dismutase manual), and for uric acid enzymatic UOD / PAP spectrophotometric method, ( Trinder Color Kit , Wiener Lab) was used.
85% of the patients developed oral mucositis. SOD concentration in the M stage was significantly higher (p<0.01) compared with stage I, and it reversed in stage F. UA concentration was significantly lower (p<0.001) in stage M compared with stage I, and in stage F it recovered the initial values.
SOD increase in stage M coincided with the appearance of mucositis, which could be interpreted as a defensive mechanism of saliva against oxidative stress produced by chemotherapy. UA decrease in stage M would favour the development of higher degrees of mucositis.